CheckEmoji Community · the emoji forum
🏠 Home 🆕 What's new ❓ Unanswered 🔥 Popular 📡 RSS Members 👥 0 online log in · register
Home › Chris Clark7 › Posts

Posts by Chris Clark7

4 posts shown.

Intestinal Passage in Health ·
I have a quick question for you all, and I was wondering if anyone else experienced some stomach pain after eating that processed stuff from Burger King, specifically once things started moving through their digestive tract. I’ve been dealing with this for about two days now... it honestly feels like I have stones sitting in my stomach. I haven't been able to find anything helpful online regarding this specific issue. I guess I am just curious to know what your experiences have been like.
I went ahead and read through everything on the Osiris Therapeutics site that bluerider2 linked to earlier. Regarding the Chron treatment specifically—which is what I'm really looking into—it’s currently only been tested on about ten patients, but they've seen some pretty significant progress after just two rounds of therapy, which seems quite promising. From what I can gather, it's moving into phase three of the clinical trials right now, and they're actually accepting applications for people who want to participate in the study. This initial testing period lasted about 28 weeks, and even within that relatively short window of monitoring the patients, the results were impressive. They measure the stage of Chron using certain indices, and according to those metrics, the outcomes have been very strong. So, we're seeing real improvement in a very short amount of time. Now that they're entering phase three, they'll be expanding to a much larger group of patients across multiple different centers over a longer duration. That's when we'll really see how the body reacts; I guess there's always a chance some nasty side effects might show up, though none have been reported so far. I also happened to see somewhere that their stock price has taken quite a jump, so here is the chart...

http://www.nasdaq.com/asp/quotes_rep...&selected=OSIR

As you can tell, Wall Street definitely recognized these positive research results. Since mid-October 2008, the stock has climbed from $11 to $21 per share. It's worth keeping in mind the kind of recession the world was dealing with back then, too. Sometimes, a move like this can be quite telling. 🙂
So, I was reading this massive feature in the Democratic Party's main publication yesterday regarding this medication. It was easily five or six pages long, and I have to say, the tone was incredibly optimistic. On one hand, it’s really encouraging, though I suppose the main catch is that we are still quite a long way from seeing it actually become a reality. Toward the end of the piece, it mentioned—I can't quite recall the specific source—that they estimate the drug might enter large-scale production here in the USA within a year, and then maybe another six months after that before it even reaches our local clinics, so I guess there is still plenty of time to wait. The big question mark remains how those upcoming studies will pan out, specifically that third phase involving such a huge number of patients. But, if there is a silver lining, it’s that the article featured a ton of American specialists from all sorts of different fields. Honestly, whether it was diabetes, Chron, or just general medicine, every expert I read about seemed extremely positive about the drug's potential. Even Rajko Ostojić spoke up regarding Chron. So, yeah, that's pretty much it.
This sounds incredibly interesting, and I actually ended up asking about this earlier over in the thread regarding Chronov disease, so I’m really glad you decided to start a dedicated topic for it. I guess I'm hoping maybe someone with a bit more expertise in this field might jump in and write a more detailed breakdown of what's going on. I was wondering where you found that pricing information, though? It seems pretty steep to me, but I suppose it's encouraging to know they're actually working on it, so perhaps the cost might eventually come down enough to make it accessible for people who might struggle to afford something like this right now.